Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

BACKGROUND: Programmed cell death ligand-1 (PD-L1) expression has been reported in up to 61% of high grade gliomas (HGG). The purpose of this study was to describe safety and efficacy of PD-1 inhibition in patients with refractory HGGs. METHODS: This Institutional Review Board approved single center...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiss, Samantha N., Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735528/
https://www.ncbi.nlm.nih.gov/pubmed/29254497
http://dx.doi.org/10.1186/s40425-017-0302-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735528/
https://www.ncbi.nlm.nih.gov/pubmed/29254497
http://dx.doi.org/10.1186/s40425-017-0302-x

Ejemplares similares